GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Pharmala Biotech Holdings Inc (OTCPK:MDXXF) » Definitions » General and Admin. Expense

MDXXF (Pharmala Biotech Holdings) General and Admin. Expense : $0.83 Mil (TTM As of Feb. 2025)


View and export this data going back to 2023. Start your Free Trial

What is Pharmala Biotech Holdings General and Admin. Expense?

General and Admin. Expense is the aggregate total of general managing and administering expenses for the company. Pharmala Biotech Holdings's General and Admin. Expense for the three months ended in Feb. 2025 was $0.55 Mil. Its General and Admin. Expense for the trailing twelve months (TTM) ended in Feb. 2025 was $0.83 Mil.

Pharmala Biotech Holdings General and Admin. Expense Historical Data

The historical data trend for Pharmala Biotech Holdings's General and Admin. Expense can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Pharmala Biotech Holdings General and Admin. Expense Chart

Pharmala Biotech Holdings Annual Data
Trend Aug21 Aug22 Aug23 Aug24
General and Admin. Expense
1.96 0.71 0.86 0.88

Pharmala Biotech Holdings Quarterly Data
May21 Aug21 Nov21 Feb22 May22 Aug22 Nov22 Feb23 May23 Aug23 Nov23 Feb24 Aug24 Nov24 Feb25
General and Admin. Expense Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 0.13 0.15 - 0.28 0.55

Pharmala Biotech Holdings General and Admin. Expense Calculation

General and Admin. Expense is the aggregate total of general managing and administering expenses for the company.

General and Admin. Expense for the trailing twelve months (TTM) ended in Feb. 2025 adds up the quarterly data reported by the company within the most recent 12 months, which was $0.83 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Pharmala Biotech Holdings General and Admin. Expense Related Terms

Thank you for viewing the detailed overview of Pharmala Biotech Holdings's General and Admin. Expense provided by GuruFocus.com. Please click on the following links to see related term pages.

Pharmala Biotech Holdings Business Description

Industry
GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Pharmala Biotech Holdings Inc (OTCPK:MDXXF) » Definitions » General and Admin. Expense
Comparable Companies
TSX:RVX TSXV:IOT XCNQ:BIOV XCNQ:BLAB TSXV:CYTO TSXV:KNE TSXV:RKV TSX:CSCI XCNQ:GLOW TSXV:SHRX VRTX ASX:CSL REGN XKRX:207940 ALNY XBRU:UCB XBRU:ARGX ONC XKRX:068270 BNTX
Traded in Other Exchanges
MDMA:Canada
Address
1 Adelaide Street East, Suite 801, Toranto, ON, CAN, M5C 2V9
Website
https://www.pharmala.ca
Pharmala Biotech Holdings Inc is focused on manufacturing and sales of MDMA and MDXX Active Pharmaceutical Ingredients (API) for use in clinical research. Its drug API is manufactured and encapsulated under GMP conditions. The company generates revenue from the sale of tablets and raw MDMA and MDXX compounds/formulations and royalties from licensing of its IP.